Equities

Establishment Labs Holdings Inc

Establishment Labs Holdings Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)48.12
  • Today's Change-3.63 / -7.01%
  • Shares traded355.32k
  • 1 Year change-27.52%
  • Beta1.2704
Data delayed at least 15 minutes, as of Jun 07 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.

  • Revenue in USD (TTM)155.79m
  • Net income in USD-82.76m
  • Incorporated2013
  • Employees781.00
  • Location
    Establishment Labs Holdings IncBuilding B15 And 25 Coyol Free ZoneALAJUELA VG1110Costa RicaCRI
  • Phone+506 24342400
  • Websitehttps://establishmentlabs.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Silk Road Medical Inc185.49m-53.42m838.58m474.00--5.69--4.52-1.37-1.374.763.730.72472.087.87391,322.80-20.87-29.02-22.75-32.9873.3172.91-28.80-46.849.62--0.34--27.7738.66-1.33---7.92--
Avanos Medical Inc680.10m-1.60m933.69m3.77k--0.763121.321.37-0.0315-1.3314.6226.650.40051.625.48180,350.00-0.0942-0.6527-0.1055-0.733856.3354.45-0.2353-1.601.474.850.1257---1.580.6357-146.05---18.37--
BioLife Solutions Inc137.30m-62.93m978.62m409.00--2.91--7.13-1.43-1.433.107.300.32382.175.61335,687.00-14.84-13.76-16.52-15.0432.9736.76-45.84-42.991.77-32.080.0717---11.4348.6552.49--86.35--
Artivion Inc368.21m-9.58m982.01m1.50k--3.3372.072.67-0.2615-0.26158.647.070.47791.645.37245,470.70-1.25-2.20-1.33-2.3664.7565.51-2.61-5.344.262.260.5176--12.826.14-60.09--5.13--
MiMedx Group Inc334.51m71.52m1.05bn895.0018.856.7313.153.130.37670.33932.151.061.722.826.58373,754.2041.80-4.1453.13-5.9083.5083.6124.36-2.702.719.000.111--20.03-2.19310.29---26.47--
AtriCure Inc414.60m-37.23m1.08bn1.20k--2.38--2.62-0.8005-0.80058.929.430.70591.708.21345,501.70-6.34-3.72-7.08-4.1075.2674.36-8.98-7.642.83-10.270.1212--20.8414.6434.49--46.56--
Coretag Inc0.00-34.52k1.13bn0.00---------0.3806-0.38060.00-0.98010.00-------3,303.35--------------------------10.95------
Adapthealth Corp3.25bn-695.41m1.27bn10.70k--0.872--0.3925-5.18-5.1824.2710.970.663721.668.30303,555.90-14.15-4.34-15.82-4.8918.4518.28-21.32-6.471.112.080.6025--7.73---1,169.99------
Alphatec Holdings Inc511.63m-191.60m1.33bn839.00--36.03--2.60-1.49-1.493.970.42940.76121.346.70609,808.10-28.51-30.97-37.13-39.4765.8966.02-37.45-46.221.49-5.170.8938--37.4539.38-23.36--67.92--
Owens & Minor, Inc.10.42bn-38.77m1.34bn13.70k--1.505.320.1286-0.5099-0.5099136.9811.711.986.7914.60760,861.20-0.73721.32-1.112.0720.7516.48-0.37190.56140.56482.190.70650.7983.801.87-284.47--25.91--
Establishment Labs Holdings Inc155.79m-82.76m1.43bn781.00--25.02--9.15-3.15-3.155.912.070.60950.91913.39171,579.30-32.38-33.22-39.25-41.1265.0164.73-53.12-43.192.73-21.300.7715--2.1321.96-4.38--69.16--
Inmode Ltd466.26m181.11m1.63bn581.009.141.958.963.492.112.115.429.870.59731.7116.09802,509.4023.2031.3225.2135.6483.1084.4638.8439.6512.66--0.000.008.3237.4922.5454.6513.10--
LeMaitre Vascular Inc199.89m33.95m1.76bn614.0052.045.7240.538.821.511.518.8913.740.59771.177.19325,548.9010.159.0210.999.9366.4565.8316.9915.455.31--0.0040.4119.6912.8845.895.9618.9315.51
Premier Inc1.34bn80.33m2.00bn2.80k29.731.0410.171.500.64210.642111.3418.350.38875.253.10477,306.101.8910.392.4813.0066.2062.044.8722.600.8226143.620.27619.11-6.762.44-34.17-15.30-2.29--
UFP Technologies Inc407.33m47.88m2.00bn3.09k42.056.7933.654.926.216.2152.8238.461.024.506.71131,693.2011.999.6913.8010.9527.8926.3311.7510.141.4617.870.10390.0013.0816.007.5025.7114.08--
Data as of Jun 07 2024. Currency figures normalised to Establishment Labs Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

55.10%Per cent of shares held by top holders
HolderShares% Held
JW Asset Management LLCas of 31 Mar 20243.19m11.74%
RTW Investments LPas of 31 Mar 20242.68m9.84%
Brown Advisory LLCas of 31 Mar 20242.32m8.52%
Nantahala Capital Management LLCas of 31 Mar 20241.96m7.22%
Cowen & Co. LLCas of 31 Mar 2024939.95k3.46%
Capital Research & Management Co. (Global Investors)as of 31 Mar 2024901.53k3.31%
JPMorgan Investment Management, Inc.as of 31 Mar 2024826.94k3.04%
Findell Capital Management LLCas of 31 Mar 2024785.02k2.89%
Rice, Hall, James & Associates LLCas of 31 Mar 2024738.02k2.71%
Morgan Stanley & Co. LLCas of 31 Mar 2024648.13k2.38%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.